Samenvatting

Introduction: The evaluation of the potential carcinogenicity is a key consideration in the risk assessment of chemicals. Predictive toxicology is currently switching towards non-animal approaches that rely on the mechanistic understanding of toxicity. Areas covered: Adverse outcome pathways (AOPs) present toxicological processes, including chemical-induced carcinogenicity, in a visual and comprehensive manner, which serve as the conceptual backbone for the development of non-animal approaches eligible for hazard identification. The current review provides an overview of the available AOPs leading to liver cancer and discusses their use in advanced testing of liver carcinogenic chemicals. Moreover, the challenges related to their use in risk assessment are outlined, including the exploitation of available data, the need for semantic ontologies, and the development of quantitative AOPs. Expert Opinion: To exploit the potential of liver cancer AOPs in the field of risk assessment, 3 immediate prerequisites need to be fulfilled. These include developing human relevant AOPs for chemical-induced liver cancer, increasing the number of AOPs integrating quantitative toxicodynamic and toxicokinetic data, and developing a liver cancer AOP network. As AOPs and other areas in the field continue to evolve, liver cancer AOPs will progress into a reliable and robust tool serving future risk assessment and management.
Originele taal-2English
Pagina's (van-tot)425-438
Aantal pagina's19
TijdschriftExpert Opinion on Drug Safety
Volume23
Nummer van het tijdschrift4
DOI's
StatusPublished - 4 apr 2024

Bibliografische nota

Publisher Copyright:
© 2024 Informa UK Limited, trading as Taylor & Francis Group.

Vingerafdruk

Duik in de onderzoeksthema's van 'Chemical-induced liver cancer: an adverse outcome pathway perspective'. Samen vormen ze een unieke vingerafdruk.

Citeer dit